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Abstract 
Two geographically distant M. tuberculosis sublineages, Tur from Turkey and T3-Osaka from 
Japan, exhibit partially identical genotypic signatures (identical 12-loci MIRU-VNTR 
profiles, distinct spoligotyping patterns).  
We investigated T3-Osaka and Tur sublineages characteristics and potential genetic 
relatedness, first using MIRU-VNTR locus analysis on 21 and 25 samples of each sublineage 
respectively, and second comparing Whole Genome Sequences of 8 new samples to public 
data from 45 samples uncovering human tuberculosis diversity. We then tried to date their 
Most Recent Common Ancestor (MRCA) using three calibrations of SNP accumulation rate 
(long-term=0.03 SNP/genome/year, derived from a tuberculosis ancestor of around 70,000 
years old; intermediate=0.2 SNP/genome/year derived from a Peruvian mummy; short-
term=0.5 SNP/genome/year). To disentangle between these scenarios, we confronted the 
corresponding divergence times with major human history events and knowledge on human 
genetic divergence. 
We identified relatively high intrasublineage diversity for both T3-Osaka and Tur. We 
definitively proved their monophyly; the corresponding super-sublineage (referred to as “T3-
Osa-Tur”) shares a common ancestor with T3-Ethiopia and Ural sublineages but is only 
remotely related to other Euro-American sublineages such as X, LAM, Haarlem and S.  
The evolutionary scenario based on long-term evolution rate being valid until T3-Osa-Tur 
MRCA was not supported by Japanese fossil data. The evolutionary scenario relying on short-
term evolution rate since T3-Osa-Tur MRCA was contradicted by human history and 
potential traces of past epidemics. T3-Osaka and Tur sublineages were found likely to have 
diverged between 800y and 2,000 years ago, potentially at the time of Mongol Empire.  
Altogether, this study definitively proves a strong genetic link between Turkish and Japanese 
tuberculosis. It provides a first hypothesis for calibrating TB Euro-American lineage 
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molecular clock; additional studies are needed to reliably date events corresponding to 
intermediate depths in tuberculosis phylogeny. 
283 words. 
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1. Introduction 
Tuberculosis (TB), caused by bacteria in the Mycobacterium tuberculosis complex (MTBC), 
is the second most prevalent infectious disease, with about 8.6 million cases every year. It is 
an ancient airborne infectious disease affecting both humans and domestic animals (Grmek, 
1994; Palfi et al., 2015; WHO, 2013). Seven lineages have been identified up to now: three 
‘ancient’ i.e. having likely diverged rapidly after the Most Recent Common Ancestor 
(MRCA): lineage 1-EAI and two M. africanum lineages termed 5 and 6; three ‘modern’ 
(lineages 2, 3, 4), and one intermediate (lineage 7) recently described in Ethiopia (Blouin et 
al., 2012; Firdessa et al., 2013). Dating the emergence of the MTBC and main diversification 
events is both of fundamental and applied interest: it is a necessary step for identifying 
correlation between ecological conditions and tuberculosis evolution, which can in turn 
provide better predictions of outbreak risks.  
 
1.1. Long-term substitution rate differs from short-term mutation rate 
Dating past evolutionary events is a difficult task. For macro-organisms, a comfortable 
but rarely existing situation is to have a series of dated fossils sharing distinctive phenotypes 
(Ho et al., 2011). For all other situations, common practice is to infer the evolution rate of one 
molecule and apply it to phylogenies linking present samples (Perler et al., 1980). Inferring 
DNA evolution rate can be achieved indirectly using a dated fossil, or directly in pedigrees, 
laboratory lines, or through heterochronous sampling (Ho et al., 2011). The two methods in 
fact give different results both in macro- and micro-organisms: the indirect method integrates 
evolutionary mechanisms related to demography and environment such as random sorting and 
selection, which impacts depend on the gene and on the position of the mutation in the codon 
(Kuo and Ochman, 2009; Parsons et al., 1997). The long-term evolutionary rate is classically 
referred to as “substitution rate”. Substitution rate can be as much as 10 times lower than the 
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short-term evolution rate depending on the species and its population dynamics (Ho et al., 
2011; Howell et al., 2003; Soares et al., 2009).  
 
1.2. Current knowledge on tuberculosis evolution rate  
Short-term evolutionary rate in M. tuberculosis complex has been estimated to be 
between 0.3 and 0.5 punctual mutations per genome per year (also referred to as Single 
Nucleotide Polymorphism or SNP per genome per year) which corresponds to an annual rate 
per site of 6.8 x 10
-8
 to 1.1 x 10
-7
 (Bryant et al., 2013; Ford et al., 2011; Guerra-Assuncao et 
al., 2015; Roetzer et al., 2013; Walker et al., 2013). Mutation rate was also assessed directly 
using whole genome sequence of a tuberculosis sample extracted from a 1,000-year old 
Peruvian mummy: it was measured as 4.8 x 10
-8
 SNP/site/year i.e. 0.22 SNP/genome/year 
(Bos et al., 2014).  
To infer long-term evolutionary rate of MTBC, several fossils may be considered. 
Turkish Homo erectus remains showing bone lesions partly similar to those caused by MTBC 
suggest that a TB ancestor could have infected human lineage at least 0.5 million years ago. 
No molecular data however are available to support presence of MTBC DNA in these 
remains. The corresponding mutation rate, in the range of 10
-10
 per site per year, would be 
surprisingly low as compared to that of other bacteria (Comas et al., 2013; Kappelman et al., 
2008; Roberts et al., 2009). Detection of M. tuberculosis ancient DNA has occurred in more 
recent fossils: molecular analyses of palaeolithic bison bone remains showed a case of 
infection 17,000 years ago  in North America; several fossils dating from more than 7,000 
years ago are known since early 20
th
 century in Eastern Europe and Middle East: the most 
ancients are 9,000 years old and were found in Atlit Yam in Israël; they harbor genetic 
features suggesting that they belong to a “modern” lineage (Hershkovitz et al., 2008; Masson 
et al., 2015); others in Italy, Hungary date back to 7,000  years ago (Bartels, 1907).  
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Notwithstanding direct estimation of mutation rate using fossils, long-term M. 
tuberculosis evolution rate has been estimated using the assumption of host codivergence 
(Comas et al., 2013; Kuo and Ochman, 2009). From the three hypotheses tested by Comas et 
al. (2013), namely 1) TB divergence upon emergence of anatomically modern humans circa -
185,000 years ago, 2) divergence coincident with the out-of-Africa expansion circa -70,000 
years ago, and 3) divergence during the Neolithic transition circa -12,000 years ago, the -
70,000 years ago hypothesis provided the best match with human paths of migration: the first 
modern human migration towards East Asia coincides with the emergence of the East-
African-Indian (EAI) clade (lineage 1). In addition, the increases of the effective population 
size derived from present diversity were found contemporaneous to important events in 
human history: a first tuberculosis expansion around -30/-20,000 years ago, when human 
populations first rose to an effective population size close to 1,000 individuals, and a second 
pronounced increase between -8 and -4 kya in a period of great human expansion associated 
with agriculture onset (Comas et al., 2013). The corresponding substitution rate was described 
to be 2.58 x 10
-9
 substitutions per site per year; it matches that derived from enterobacteria 
divergence as used for first inferences on the age of MTBC MRCA (Gutierrez et al., 2005; 
Hughes et al., 2002).  
Accepted estimates of M. tuberculosis annual mutation rate therefore range from 2.58 
x 10
-9
 for the long-term to approximately 10
-7
 for the short term. If these estimates are true, 
the question becomes how and when evolution rate switches from one rate to the other.  
Two studies have tried to infer intermediate evolutionary events using either long-term 
or short-term mutation rates. Using the long-term evolution rate that they had derived (-
70,000 years  hypothesis), two expansions have been described in the Beijing lineage (lineage 
2) as dating back to respectively 1) between -10,000 and -6,000 years ago and 2) between -
5,000 to -3,000 years ago, i.e. at the time of human Neolithic expansions. This matches 
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known human history and potentially further supports expansion -70,000 years ago (Comas et 
al., 2013). Accordingly, long-term substitution rate seems valid until the divergence of the so-
called “modern lineages” (lineages 2, 3 and 4) expansions. Another study focusing on the 
Beijing lineage argues that the implementation of a short-term mutation rate of 10
-7
 
SNP/site/year (i.e. 38.8 times faster mutation rate) leads to a convincing evolutionary history 
from the demographic explosion of Beijing lineage on, as Beijing expansion would coincide 
with human demography (Merker et al., 2015): first expansion upon the onset of industrial 
revolution in the 19
th
 century (1822-1843) i.e. around 180 years ago, stasis linked with 
increased hygiene on the turn of 20
th
 century, second burst associated with First World War or 
slightly before (1896-1916), around 110 years ago, decline associated with antibiotic era in 
1966, and reactivation linked with HIV starting around 1987. This implies that the short-term 
evolutionary rate would be valid at least for the last 180 years. However when applying the 
short-term rate for a period of 180 years, the number of mutations is the same as that derived 
from the long-term substitution rate for ~7,000 years ago, i.e. 80/90 SNPs. This observation 
means that the same first molecular signal has been interpreted as an expansion dating back to 
7,000  or 180 years ago. Conversely, the same second signal (55 SNPs divergence) was 
interpreted dating back to either ~3/4,000 or ~110 years ago. As the same genetic divergence 
cannot account for expansions at different time points, the contradiction between these two 
analyses can indicate either that one of two applied rate does not apply for a range of 50/100 
SNPs or that none of these rates can apply. Correspondence between inferred tuberculosis 
demography and known human demography could have arisen solely by chance as both M. 
tuberculosis and human demography seem to have followed a recurrent pattern of expansions 
and stases. Additional studies are needed to propose new calibration points and thereby build 
a more complete and accurate model of tuberculosis history.  
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1.3. Definition and general characteristics of Tur and T3-Osaka sublineages 
Our attention was caught by the potential relatedness between two MTC sublineages, 
the Turkish and the T3-Osaka. These two sublineages were first defined based on standard 
genotyping methods: Insertion sequence-based polymorphism (IS6110-RFLP), combined 
mini-satellites analysis (12-loci MIRU-VNTR
1
), profile at the CRISPR
2
 locus (spoligotype) 
with specific deletions (Fig. 1).  
The Turkish (Tur) sublineage was first described in Turkey where it represents 10 to 
30% of all clinical isolates depending on regions, and named as “LAM7-Tur” in 2005 
(Durmaz et al., 2007; Kisa et al., 2012; Oral Zeytinli and Koksal, 2012; Otlu et al., 2009; 
Zozio et al., 2005). The absence of phylogenetic relationship with other LAM sublineages 
such as the absence of ligB synonymous mutation C1212G led to its progressive renaming as 
Tur (Abadia et al., 2010; Dos Vultos et al., 2008). This lineage has been identified in several 
neighboring countries such as Bulgaria (Valcheva et al., 2008; Vasileva, 1992), and is 
recently spreading to Middle-East and Europe as evidenced by SIT41 map generated by 
SITVITWEB (Fig. S1A). Tur prototypic genotype carries two IS6110 copies (2.1 and 4.8 kb), 
and a characteristic 777777404760771 spoligotype signature lacking spacers 20-24, 26-27, 
33-36 (SIT41 in SpolDB4) (Fig. 1A-B). Most isolates carry a 215125113322 12-loci MIRU 
signature defined as MIRU-international-type 310 (MIT310) in SITVIT2 database (Zozio et 
al., 2005) (Fig. 1C). Isolates from the Tur sublineage have recently acquired Multi-Drug-
Resistance (MDR) and this sublineage is one of the most prevalent among MDR-TB isolates 
in Bulgaria (Gomgnimbou et al., 2013).  
The T3-Osaka sublineage was reported for the first time in Okayama district and 
nearby in Osaka in South-Japan in 2004 (Ohata and Tada, 2004). It was fully described by 
Iwamoto and coworkers as carrying one to two IS6110 copies (Takashima and Iwamoto, 
                                                 
1
 Mycobacterial Interspersed Repetitive Units-Variable Number of Tandem Repeats 
2
 Clustered Regularly Interspersed Short Palindromic Repeats 
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2006); its prototypic spoligotype is characterized by the absence of spacers 5-8, 13, 33-36 
(such as in 741777777760771 spoligotype, SIT627 in SpolDB4), and most isolates also carry 
a MIT310 signature (Fig. 1C). Variants of the SIT627 spoligotype pattern in the SITVIT2 
database (Demay et al., 2012) are almost only isolated from Japanese patients as shown in 
Fig. S1B. The SIT627 was also found in Kobe in an independent study (C. Sola & T. 
Iwamoto, unpublished). In Japan, the SIT627 is the most prevalent non-Beijing spoligotype 
pattern; it represents around 5% of clinical isolates around Okayama (Ohata and Tada, 2004), 
and recent epidemiological studies show that it is even more frequent in Yamagata (Fig. S1C). 
T3-Osaka VNTR diversity showing high frequency of MIT310 was studied in Okinawa in 
2007 (Millet et al., 2007).  
Both Tur and T3-Osaka sublineages are “low IS6110 copy” (1 or 2 copies), harbor 
most frequently a MIT310 genotype  (215125113322), but divergent spoligotypes (although 
both lack spacers 33 to 36, which characterizes the Lineage 4 also known as “Euro-
American”). Two isolates of each sublineage were later found to harbour the same specific 
G809T mutation in the DNA repair replication and recombination (3R) gene ligC (Abadia et 
al., 2010; Dos Vultos et al., 2008). In contrast, five other 3R SNPs (on recC, end, recN, ruvB, 
dinF) distinguished between T3-Osaka and Tur (Dos Vultos et al., 2008). In a method 
development study, ligC G809T mutation was detected in 18 additional Tur isolates and 25 
additional SIT627 isolates and in none of the other isolates included in that study, suggesting 
a phylogenetic link between Tur and T3-Osaka sublineages (Abadia et al., 2010).   
 
1.4. Objectives of the study 
We aimed here at proving the relatedness of these two sublineages, and if confirmed, 
at using it to calibrate in M. tuberculosis divergence rate. We first explored the intra 
sublineage diversity using 46 samples and investigating VNTR profiles on markers outside 
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the MIRU-VNTR12 panel. We then obtained whole genome sequences for eight isolates (n=3 
for T3-Osaka; n=3 for Tur; n=2 for outgroups) and analyzed them together with other 
publicly available sequences. Our results definitively confirm that these sublineages are 
highly related and emerged relatively long-time ago. We then explored different hypotheses 
regarding the age of their MRCA and compared them to data on tuberculous fossils and major 
events regarding human history and demography. Regarding M. tuberculosis molecular clock, 
we aimed at answering the following questions: 1) may long-term substitution rate be valid 
from 70,000 years ago until Tur and T3-Osaka MRCA? ; 2) may short-term substitution rate 
be valid since Tur and T3-Osaka MRCA? ; 3) if an intermediate substitution rate is needed to 
account for Tur and T3-Osaka MRCA likely age, what is its range i.e. what is the shape of the 
function describing substitution rate decrease with longer time periods?  
 
 
2. Results 
 
2.1. MIRU-VNTR diversity among Tur and T3-Osaka sublineages 
In order to characterize intra and inter-sublineages diversity, we genotyped a total of 46 
isolates characterized as Tur (n=21) or T3-Osaka (n=25). We used 9 VNTRs out of MIRU12 
panel and known to be variable between Euro-American isolates: Mtub04, Mtub21, Mtub29, 
Mtub30, Mtub39, Qub11b, Qub26, Qub4156 (Table 1). Only Mtub04 presented no common 
allele between the T3-Osaka and the Tur strains and thus might serve as a surrogate marker to 
discriminate between the two sublineages (4 or 5 repetitions for Tur; 2 or 3 repetitions for T3-
Osaka). Variants were relatively frequent, with up to four locus variations (4LV) among the 
Turkish Tur isolates at the 9 targeted VNTRs, and up to 5LV when comparing them with 
Bulgarian Tur. T3-Osaka isolates also harboured up to 5LV for the 9 targeted VNTRs and 6 
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when including others VNTRs (Table S1). Bulgarian Tur isolates harboured specific 
genotypes suggesting that they could form a sublineage inside Tur (Table 1). For the 25 T3-
Osaka samples and the 3 Tur samples from Bulgaria, for which we checked the whole 24 
MIRU-VNTR patterns, only 13 samples (46%) carried the expected MIT310 genotype and six 
of the 12 MIRUs carried at least one different allele other than that present in MIT310 (Table 
S1). MIRU10 was the most variable locus in this sample, five out of the 25 T3-Osaka samples 
having from 1 to 4 repetitions instead of 5. Consensus 12-loci MIRU signature is 
21X1251X3X2X, with ETRA-B-C signature of “324” and Mtub(04-21-29-30-34-39) 
signature of X3443X. We searched for such signature along recent data gathered from China 
and found no such isolate (data not shown). 
 
2.2. WGS sequencing and phylogenetic analysis 
To confirm relatedness and position these two sublineages in M. tuberculosis phylogeny, we 
proceeded to whole genome sequencing of prototypic specimen. Three isolates of each 
sublineage (Tur and T3-Osaka) were selected, respectively from a Bulgarian and a Japanese 
collection. One other isolate in each of the two populations was included as representative of 
the local diversity. These eight genomes were compared to 45 additional genomes 
representing the diversity of standard MTBC excluding M. canettii (Benavente et al., 2015; 
Coll et al., 2014a; Coll et al., 2014b; Firdessa et al., 2013) (Table S2). We specifically 
included an Ural strain to test the hypothesis of relatedness between Tur and Ural sublineages 
proposed by Mokrousov (2015). A total of 14,071 variable positions were identified among 
which 14,013 SNPs (Table S3).  
Phylogenetic analysis clustered the “Tur” and “T3-Osaka” isolates respectively (Fig. 2). 
Interestingly, the three “T3-Osaka” isolates diverged relatively long ago (long terminal 
branches) and at the same time. Such feature is rare in phylogenies, especially when sampling 
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is random. It may indicate a time of intense proliferation. In the case of tuberculosis, it might 
correspond to an epidemic.  
“Tur” and “T3-Osaka” sublineages clustered together with high confidence (100% as 
estimated by 500 bootstrap replications; sublineage denoted as “T3-Osa-Tur”). The 
phylogenetic analysis shows that the “T3-Osa-Tur” sublineage is related to a “T3-Ethiopia” 
sample collected in the Netherlands and an “Ural” sample collected in Germany (Fig. 2).  
We identified 74 SNPs potentially specific of “T3-Osaka” sublineage, 96 SNPs potentially 
specific of the Tur lineage and 7 SNPs specific of the “T3-Osa-Tur” sublineage (Table 2). In 
addition, a 2bp small insertion in Rv0577 was found in all “T3-Osa-Tur” isolates (Table S4). 
The lineage 4.2.2.1-specific SNP in prfA gene (Rv1299, TC in position 1,455,780) 
described by Coll et al. (Coll et al., 2014a; Coll et al., 2014b) is one of the SNPs found to be 
common to the Tur isolates: this 4.2.2.1 lineage may thus be considered as a synonym of 
“Tur” sublineage. Within the SNPs list, we confirmed 2 out of 5 candidate SNPs previously 
identified (Dos Vultos et al., 2008): ruvB was found specific of T3-Osaka isolates and recN 
specific of Tur isolates. In contrast, SNPs in recC, end, dinF were absent from any isolate 
included in this study. Among the SNPs common to the three “T3-Osaka” isolates, as the 
divergence between them is quite large (see branch length in Fig. 2) most of them may be 
characteristic of “T3-Osaka” lineage. We propose CG in genome position 7,121 in gyrB 
gene to define this sublineage.  
 
2.3. Dating the split between Turkish and T3-Osaka sub-lineages according to 
different available mutation rates 
We performed BEAST analyses to infer divergence dates using three mutation rates: one 
corresponding to the MRCA of M. tuberculosis tree of 67,000 years old according to 
congruence with human evolution (Comas et al., 2013), the second one corresponding to the 
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mutation rate derived from the Peruvian mummy i.e. 4.8x 10
-8
 mutation/site/year (17), the 
third being in the range of what was observed in clinical studies (10
-7 
mutation/site/year). 
Under the first scenario, the timing of lineages 1, 2, 3 and 4 divergence derived from our tree 
correlated well with the previously reported ages reported (Fig. S5 in Comas et al. 2013). The 
MRCA reported for the Japanese (T3-Osaka) and Turkish (Tur) was estimated to be 
approximately 12,000 years old (95% CI 10,907-12,753 years) and the divergence of T3-
Osaka isolates potentially corresponding to an epidemic around 7,500 years old (Fig. 3A and 
Fig. S2). Under the second scenario coined as “intermediate”, we came out with a T3-Osa-Tur 
MRCA of around 800 years old, i.e. dated to 1200 A.D and potential Japanese epidemic 500 
years ago (Fig. 3B and Fig. S3). The last scenario (“fast”) proposes a T3-Osa-Tur MRCA of 
around 370 years old and Japanese epidemic 230 years ago i.e. around 1780 AD (Fig. 3C and 
Fig. S4).  
 
2.4. Confronting human and tuberculosis information to assess the time of 
transition between slow and rapid mutation rate 
Fossil, human genetic and linguistic evidence was used to investigate the three scenarios of 
divergence. We searched for events: A) in Middle East and over the world possibly 
corresponding to emergence of “modern” lineages (lineages 2-4); B) in Central Asia possibly 
corresponding to colonization of Asia by TB; C) in Japan possibly corresponding to 
colonization of the country by T3-Osaka TB sublineage and later potential epidemic; D) in 
Turkey possibly corresponding to colonization of the country by Tur TB sublineage. As 
intermediate evolution rate differs from only a factor 2 from the fast (short-term) evolution 
rate, Table 3 only reports the slow and intermediate rate scenarios. We found clues 
compatible with any scenario at all time scales, however, two lines of evidence suggested that 
some scenarios are unlikely for certain time scales (Table 3). First, intermediate and fast 
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evolution rates were found poorly supported for the timeframe of Asia colonization by TB-
infected humans. Indeed only so-called “modern lineages” are found in this part of the world 
suggesting that they colonized Asia after “modern lineage” emergence; under the fast and 
intermediate evolution rate scenarios, “modern lineages” emerged around 4,000 years ago, 
which would mean that Asia would have been colonized by tuberculosis afterwards. This is 
not compatible with human remains with scars of TB found in Baïkal region and dating back 
to 4,500 years ago (Lieverse et al., 2014). Second, slow evolution rate scenario does not 
match field data linked to TB colonization of Japan: this scenario infers that MRCA of T3-
Osaka in Japan and the epidemics likely responsible of almost contemporaneous divergence 
of all 3 present isolates, would be approximately 7,500 years old (CI [8,300-6,600 years old], 
Fig. S2), however no human remains from the Jomon period (12,000-1,700 years ago) were 
found to have TB scars despite examination of more than 10,000 skeletons (Suzuki et al., 
2008). We suggest that TB proliferation having left no traces among this large sample of 
remains is unlikely. War during Sengoku period (15
th
 – 16th century) may in contrast have 
favored an epidemic (possibly 540-440 years old i.e. dating back to 1470-1570 years AD) as 
per intermediate mutation rate scenario (Table 3, Fig. S3). Such timing seems also more likely 
than that according to fast-evolution rate scenario (Fig. 3) as the potential epidemic is inferred 
to have occurred between 260 and 210 years ago i.e. between 1750-1800 AD period, in the 
middle of Edo-Tokugawa period renowned for prosperity and peace (Table 3, Fig. S4). 
Altogether, possible history of tuberculosis at the different time scales is: divergence of the 7 
main lineages more than 20,000 years ago in Africa and in the Middle East according to slow 
mutation rate scenario; divergence between T3-Osaka and Tur and subsequent dispersal 
towards Japan and Turkey, and Japanese epidemic, respectively less than 2,000 and 1,000 
years ago, possibly at the time corresponding to intermediate evolution rate scenario (i.e. 
~800 and ~400 years ago) (Fig. 4).  
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4. Discussion 
Using SNP, MIRU-VNTR data and whole genome sequencing, we investigated one of the 
rare cases of incongruence between MIRU-VNTR and spoligotyping results in M. 
tuberculosis diversity (Azé et al., 2015) and we tried to estimate their time of divergence. 
These sublineages are Turkish (Tur) and Japanese T3-Osaka (referred to as T3-Osaka) Euro-
American tuberculosis isolates carrying a low number of IS6110 copies, and belonging to the 
sublineage 4.2 (Coll et al., 2014a). We definitively proved a strong phylogenetic link between 
Tur and T3-Osaka isolates and name the corresponding lineage “T3-Osa-Tur”. We identified 
that Tur and T3-Osaka sublineages show a relatively high level of diversity, suggesting that 
their divergence is truly ancient and not the trace of contemporaneous migrations. The Tur 
sublineage diversity may even have been underestimated as included Tur samples came from 
a limited number of countries where it is present, and in Turkey, from a single city 
(Zonguldak).  The MRCA of the T3-Osa-Tur lineage likely harboured a 12-loci MIRU pattern 
concordant with that of the consensus found for both sublineages: 21X1251X3X2X, and 
potentially the most frequent genotype i.e. MIT310, 215125113322. Its spoligotype pattern 
must have exhibited no deletion specific to one of these sublineages, i. e.to have simply 
carried 33-36 spacers deletion (SIT53).  
We inferred potential ages for all MRCAs for T3-Osa and Tur sublineages along M. 
tuberculosis phylogeny using the different molecular clocks described in the literature (Bos et 
al., 2014; Bryant et al., 2013; Comas et al., 2013; Ford et al., 2011; Merker et al., 2015). 
Specific human fossils and events in human history allowed us to consider that slow evolution 
rate may not apply for the time of T3-Osaka and Tur divergence. Possible contemporaneous 
divergence between the three Japanese samples (as derived from the inferred phylogeny) 
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suggests they can have diverged at a time of intense proliferation of the sublineage. If this 
signal truly is related to a TB epidemic, the timing of this epidemic under a fast-evolution rate 
scenario is unlikely: epidemic would have occurred at a time of renowned peace and 
prosperity. Fast evolution rate thus does not seem to apply for 330-200 SNPs divergence. 
According to the evolution rate measured in the 1,000 years old Peruvian Mummy (Bos et al., 
2014), we hypothesize that T3-Osaka and Tur sublineages diverged around the beginning of 
second Millenary AD (1,000 years ago), and that T3-Osaka proliferated in Japan during the 
15
th
 or 16
th
 century (400-500 years ago). However, larger sampling would be necessary to 
confirm T3-Osaka proliferation of samples with ~200 SNPs divergence. 
We will first discuss the additional historical data compatible with tuberculosis 
phylogeny of provided by the history of Japan, of Turkey for the time of divergence between 
T3-Osaka and Tur sublineages. We then discuss others data concordant with a genetic link 
between Turkish and Japanese human populations. Last, we discuss the likely mutation rate 
corresponding to T3-Osaka and Tur divergence point and global evolution of mutation rate 
through time. 
 
4.1.  Japanese history and TB colonization of Japan  
Anthropological data suggest that the Japanese population structure lies on two pillars: The 
Jomon and Yayoi cultures (Hammer et al., 2006; Nakagome et al., 2015). Jomon people 
would have remained isolated in the Japanese archipelago since circa -16,000 years ago when 
they diverged from Tibet, Korean or North-East Asian populations whereas Yayoi are 
assumed to share a common ancestor with Chinese dating back to 5,000 years ago (Hammer 
et al., 2006; Nakagome et al., 2015; Tajima et al., 2004). In the extreme North (Ainu) and 
South (Okinawa and Tyuku), current Japanese populations are mostly from Jomon ancestry 
while in central regions, they are mostly from Yayoi ancestry (Hammer et al., 2006). 
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Subsequent migrations from diverse regions, including Korea, have occurred; potential 
admixture from Mongol populations during Mongol empire has been detected (Hellenthal et 
al., 2014). Beijing tuberculosis lineage has been proposed to have entered Japan during Yayoi 
period (Mokrousov, 2008; Suzuki and Inoue, 2007). T3-Osaka lineage could have been 
imported by a small North-East Asian population afterwards. The Sengoku period (15
th
-late 
16
th
 century, 400-500 years ago) characterized by frequent wars with Korea, China and inside 
Japan may have favoured some tuberculosis epidemics. However, earlier periods also have 
experienced wars. T3-Osaka sublineage proliferation and settlement in the country may 
altogether date from Sengoku or an earlier period.   
 
4.2. Turkish history and emergence of TB Tur sublineage 
Turkey is a mosaic of people descending mainly from nomadic tribes, some of which still 
have some representatives in Anatolian mountains. A megalithic at Urfa, East of Turkey, 
called Göbekli Tepe, confirms hunter-gatherer settlements from 13,000 to 10,000 years old 
but colonization by modern humans is inferred to have occurred 50,000 years ago from 
Middle East (Henn et al., 2012). Present Turkish populations show a strong component of 
“Eastern components” such as so-called D-cluster in mitochondrial diversity analyses (Comas 
et al., 1996). This admixture may have occurred at several time points, a stronger signal 
dating from 1,300 A.D. i.e. 700 years ago (Hellenthal et al., 2014). Historical events possibly 
having caused admixture from Asian populations into current Turkish ones are:  1) migration 
towards Mesopotamia 5,000 years ago of Yamanyan herders, descendants of Caucasus Hunter 
gatherers inhabiting North Asia since 25,000 years ago (Jones et al., 2015); 2) intense 
exchanges associated with first organized Mesopotamian civilization having set up first law 
code (Hammurabi code, 1,754 BCE i.e. 2,750 years ago) inducing migrations between 
Mesopotamia and all neighboring countries; 3) intra-empire migrations in the Hittite empire 
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set up circa 2,200 years ago, the empire encompassing present Turkey, Syria and Northern 
Mesopotamia (Kaniewski et al., 2013); 4) intra-empire migrations in the Roman Empire, 
associated with wars and colonization from 2,200 to 1,500 years ago; 5) Expansion of Turkic 
empire arisen in Mongolia around the 5
th
 century AD i.e. 1,500 years ago; 6) migrations 
caused by wars led by Mongol Empire around 600-800 years ago (Sinor, 1990). All these 
migrations events may have brought different lineages of tuberculosis to Turkey. Import of 
Tur lineage may thus in theory be due to migrations other than that of Mongols. Still, scenario 
of import by Mongols both matches the intermediate mutation rate found in M. pinnipedii and 
events in both Japanese and in Turkish history. Under this hypothesis, T3-Osa-Tur lineage 
would have emerged in Mongolia around 1,200 AD (800 years ago) almost concomitantly 
with T3_Ethiopia (Fig. 3A), and diverged around 1,250 AD (750 years ago) into T3-Osa and 
Tur sublineages (Fig. 4).  
 
4.3. Japanese-Turkish genetic and cultural relatedness 
Direct relatedness between tuberculosis sublineages may be due to host genetic relatedness 
and vertical transmission of the pathogen. Direct relatedness between Japanese and Turkish 
human populations is scarce. To our knowledge, only one common genetic pattern associated 
with schizophrenia has been described (Ozcan, 2006). Some indirect genetic relationship has 
been identified, chromosomal tracts being shared between Turkish and Mongol populations 
on one hand (Hellenthal et al., 2014; Yunusbayev et al., 2015) and some being shared by 
Japanese and Mongols on the other hand (Hellenthal et al., 2014). Common ancestry of 
Turkish and Japanese human subpopulations is thus possible. This common host ancestry 
would have transmitted the same tuberculosis sublineage, in that case, T3-Osa-Tur 
descendants. 
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Another possible cause for pathogen common ancestry is horizontal transmission due 
to cultural relationship between populations having later migrated to Japan and Turkey 
respectively. Japanese and Turkic languages show similarities grouping them into “Ural-altaic 
languages” (Cavalli-Sforza, 2000; Robbeets, 2004; Robbeets, 2008). Ural-altaic languages 
supposedly originated in South Siberia around 10,000 years ago, whereas Indo-European 
languages are believed to have arisen in Anatolia (Present Turkey) around 7,116 to 10,410 
years ago, contemporaneous to the spread of agriculture. Indo-European language was 
replaced by Turkic in Turkey starting 1600 years ago, during the 5
th
 century AD (Yunusbayev 
et al., 2015). Turkic culture expansion could have promoted the dispersal to the West of 
tuberculosis sublineages such as Tur. 
On the Japanese side, linguistics suggests that Okhtosk people (hunter-gatherer) may 
have migrated from the Eastern China Amur river basin to northern Hokkaido around 900-
1,600 years ago bringing significant contributions to the preexisting Jomon culture (Lee and 
Hasegawa, 2013). These migrations may have helped tuberculosis sublineages spread, and 
possibly that of T3-Osaka ancestor. These links, which are anterior to Mongol Empire 
invoked above, slightly predate T3-Osaka-Tur MRCA derived from intermediate evolutionary 
rate. They thus present an alternative hypothesis linking Japanese and Turkish tuberculosis 
during first Millenary AD. 
Altogether, Central Asia, and more precisely Mongolia, has been connected to Japan 
and Turkey at several points of human history. Mongolia could be the place of birth of T3-
Osa-Tur lineage. Further investigations on MIT310 variants in this part of the world should 
shed more light on this question. The fact that no sublineage related to T3-Osaka has been 
reported in neighboring Asian countries is surprising. However, islands are known to provide 
isolation that can help rare genotypes to thrive. 
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4.4. Molecular evolution rate of tuberculosis 
We have presented arguments suggesting that a slow molecular clock should be applied to 
infer ancient TB history, such as emergence of modern lineages more than 30,000 years ago 
(Comas et al., 2013). As our samples exhibited around 1,900 SNPs divergence, the 
corresponding mutation rate is 0.03 SNP/genome/year i.e. 6.2x10
-9
 SNP/site/year. This is 
slightly higher than the 2.9x10
-9
 SNP/site/year rate reported by Comas et al. (Comas et al., 
2013). This difference likely is due to differences in SNPs filtering when handling raw 
sequencing data.  
At the time scale of T3-Osa-Tur emergence (400 SNPs divergence, possibly corresponding 
~1,000 years ago), our preferred scenario is characterized by an “intermediate” mutation rate 
of 4.8 x 10
-8 
SNP/site/year i.e. around 20-times faster. The “intermediate” mutation rate was 
derived from the animal sublineage M. pinnipedii that had infected a 1,000 y-old Peruvian 
man preserved by mummification (Bos et al., 2014). The fact that it provided a convincing 
scenario for T3-Osa-Tur divergence may be due: 1) either to true conservation of the 
substitution rate across tuberculosis lineages whatever the host, 2) or to local convergence in 
the evolution rates in T3-Osa-Tur human sublineage and animal lineages (human tuberculosis 
populations evolved under limited selective pressure may accumulate similar mutations as 
animal bacilli evolving under positive selection associated to host switches); 3) or to a mere 
artefact: the sublineage of interest could have diverged at a different time point and we simply 
did not find evidence contradicting this scenario.  
We concluded that the same substitution rate cannot be applied at all time scales of 
tuberculosis phylogeny and that 1) Short mutation rate applies at least for the last ten years BP 
i.e. for a distance of around 10 SNPs, 2) Slow evolution rate applies at least around 70ky BP 
i.e. for a distance of around 1900 SNPs, and 3) intermediate mutation rate of 10
-7
 
SNP/site/year may apply for T3-Osa-Tur divergence which corresponds to a mean difference 
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of 330 SNPs in our sample. When plotting these mutation rates as a function of SNP 
divergence, we observed a very good exponential correlation (R²=0.99; Fig. 5). We used the 
regression curve to predict the emergence of Ural sublineage that is characterized by a 
divergence of 470 SNPs. We inferred that it diverged ~1800 years ago i.e. 3th century AD. 
This prediction matches previously proposed scenario locating its origin in Samartia during 
Scythia empire, between 5
th
 century BC and 4
th
 century AD (Mokrousov, 2012). Current 
progress in understanding sublineages phylogeny will help subsequent calibrations of M. 
tuberculosis molecular clock (Mokrousov et al., 2016). 
Several parameters may be responsible for the large impact of divergence (i.e. time) 
on mutation rate (Ho et al., 2011). Selection can increase mutation rate and its effect can be 
emphasized by bottlenecks, however little selection signals have been detected in tuberculosis 
genome (Dos Vultos et al., 2008; Hershberg et al., 2008; McEvoy et al., 2012). For 
pathogens, transmission may also affect mutation rate by decreasing generation time and 
fostering selection associated to host switch. Indeed latency in tuberculosis could theoretically 
be associated with longer generation time. No difference in mutation rate between latent and 
active tuberculosis has by now been detected (Ford et al., 2011). Still, resistance acquisition 
rate was found higher in Beijing lineage (Ford et al., 2013), suggesting that global mutation 
rate may vary inside tuberculosis phylogeny. 
 
5. Conclusion 
We showed here that Tur and T3-Osaka M. tuberculosis genotypes are closely related and 
exhibit ~ 330 SNPs divergence. The specific human history of Japan suggests that T3-Osaka 
penetrated Japan between 500 to 1,000 years ago and potentially participated to an epidemic 
during the Sengoku period (15
th
-late 16
th
 century).  
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Only intermediate mutation rate derived from the Peruvian mummy isolate could account for 
this scenario. This mutation rate is ~10 times higher than that corresponding to emergence of 
human tuberculosis lineages (1,900 SNPs and 70,000 years ago time-scale), and twice lower 
than that derived from contemporaneous epidemics (10 SNPs and ~10 years time-scale).  
Altogether this study supports an exponential decrease of tuberculosis mutation rate with 
divergence. Whether tuberculosis mutation rate is similar in all sublineages at each time scale 
remains to be tested. When doing so, an important issue will be the standardization of whole 
genome sequences processing.  
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Material and Methods 
 
Clinical isolates and DNA 
Two sets of DNA were used. A first set of 43 DNAs (25+18) was provided by Dr. T. 
Matsumoto and Dr. E. Aktas respectively. DNA was extracted from as many clinical isolates 
of Mycobacterium tuberculosis, from patients living in Japan (Osaka region) and having 
previously shown to harbour the SIT627 spoligotype for T3-Osaka sublineage, and from 
patients living in Turkey (Zonguldak region) and having previously shown to harbour the 
SIT41 spoligotype (Aktas et al., 2008) for Tur sublineage.  
The second set is composed by DNAs from 4 Japan clinical isolates, all exhibiting a low 
IS6110 copy number, suggesting that they could belong to the T3-Osaka genomic family, and 
DNAs from 4 Bulgarian isolates, 2 carrying SIT41, one carrying spoligotype patterns likely 
derived from SIT41, and an outgroup chosen among T1 family. They were respectively 
prepared by T. Matsumoto (Osaka, Japan) and by S. Panaiotov (Bulgaria). DNAs were sent to 
U.K. for WGS via France. No ethical committee agreement was asked for this study, since 
DNAs were obtained locally within the frame of classical diagnostics or molecular 
epidemiological investigations. No electronic file with patient name was ever created and all 
isolates are anonymous and cannot be linked to a patient name. 
 
Spoligotyping, MIRU-VNTR  
Spoligotyping was performed for all isolates using the microbead-based method (Luminex 
Corp. Austin, Texas) as previously published (Zhang et al., 2010).  
MIRU-VNTR analyses were performed for 9 loci (Mtub04, Mtub21, Mtub29, Mtub30, 
Mtub34, Mtub39, Qub11b, Qub26, Qub4156) on agarose gels in simplex as described 
previously in the IGEPE team in Orsay (Zhang et al., 2011).  
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Sanger Sequencing and Whole Genome Sequencing 
The LigB and LigC genes of the 43 DNA mentioned above were sequenced on a 4 capillary 
ABI3100 sequencer and using the same primers as those described in Dos Vultos et al (Dos 
Vultos et al., 2008). Whole genome sequencing was performed at the KAUST genomic 
facility and coordinated by the London School of Hygiene & Tropical Medicine (LSHTM, 
Pathogenseq consortium, http://pathogenseq.lshtm.ac.uk/). The genomes are part of large 
drug-resistance and strain diversity studies (Benavente et al., 2015; Coll et al., 2014a; Coll et 
al., 2014b).   
 
SNPs extraction and phylogenetical analysis 
SNPs were extracted using the following filters: exclusion of reads mapping to several loci; 
70% allelic frequency; 10 reads minimal coverage; exclusion of missing calls at the point of 
inflexion among full dataset of samples. Because reads mapping to several loci were 
excluded, we missed most of PE-PPE sequences. We did not further exclude SNPs in PE-PPE 
genes remaining sequences but they represented a minority of the SNPs (n=669; 4.8%). The 
phylogenetic tree based on WGS data was built using MEGA v.6 based on a string of 
concatenated SNPs deprived of information concerning position in codon (n=14,013) and  
was midpoint rooted (Kumar et al., 2004).   
 
Dating the split between Turkish and T3-Osaka sub-lineages 
BEAST software was used to estimate a split date between the Japanese and Bulgarian (of the 
Tur family) samples (Drummond and Rambaut, 2007). The software uses a Bayesian 
framework to estimate parameters from the sequence alignments and selected priors; it can 
implement either a given age of MRCA or a specific mutation rate to estimate the ages of the 
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internal nodes. Publically available samples data were included to represent the lineages 1-4 
(lineage 1-EAI  red, lineage 2-Beijing brown, lineage 3-CAS green, lineage 4-Euro American 
cyan, lineage 7 purple, lineage 5-Afri2 and lineage 6-Afri1 light and dark blue) (Benavente et 
al., 2015; Coll et al., 2014a; Coll et al., 2014b). In the first analysis, the root of the tree (i.e. 
the MRCA of lineages1-4) was fixed to 67,000 years as advised by Gagneux and coworkers, 
which corresponds to a mutation rate close to 6.2x10
-9
 mutation/site/year as per the mean 
number of SNPs between our samples (Comas et al., 2013). In the second analysis, the 
mutation rate was fixed at 4.9x10
-8
 mutation/site/year based on compute mutation rate of 
Peruvian body of 1,000 years old (Bos et al., 2014). In the third analysis, 10
-7
 
mutation/site/year based on several recent estimations was used (Bryant et al., 2013; Ford et 
al., 2011; Walker et al., 2013). All models used strict molecular clocks with the HKY 
substitution model. Lineage 1,2,3,4 and 7 were set as a monophyletic taxon set. 
Note that MRCA ages were given in number of years ago (i.e. Before Present), while some 
historical data were also given as compared to Anno Domini (AD, or BC for Before Christ as 
in the Christian calendar).  
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Legend to Tables : 
Table 1: MLVA (Mtub and Qub) data on the investigated clinical isolates.  
Table 2 : SNPs characteristic of T3-Osa-Tur lineage. 
Table 3: Human and TB palaeontology supporting different evolutionary rate scenarios  
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Legend to Figures 
 
Figure 1- Typical and related genotypes used to define Tur and T3-Osaka families 
(IS6110-RFLP, spoligotypes and VNTR profiles). A. LAM7-Tur isolates described by 
Zozio et al. 2005; B. T3-Osaka isolates VNTR, IS6110-RFLP and Spoligotypes found by 
Tomoshige Matsumoto et al., unpublished results 
Figure 2. SNP-based tree NJ built featuring T3-Osaka and Tur relatedness. The 
phylogeny resulting from these data shows very high robustness of almost all branches (see 
bootstrap values) due to the absence of recombination in the selected data. We observe a high 
relatedness between all isolates belonging to the same sublineage and detect that T3-Osaka 
and LAM7-Tur sublineages are forming a monophyletic group. 
Figure 3.  Dating of M. tuberculosis major evolutionary events according to the different 
evolutionary rates: A. slow mutation rate scenario (calibrated with 67,000 years as root). B.  
intermediate mutation rate scenario (4.8 x 10
-8
 SNP/genome/year). C. fast mutation rate 
scenario (10
-7
 SNP/genome/year).  
Figure 4. A possible scenario for tuberculosis phylogeography in Europe and Asia featuring 
T3-Osaka and Tur emergence. 
Figure 5. Mutation rate as a function of pairwise divergence. 
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Table 1: MLVA (Mtub and Qub) data on the investigated clinical isolates. Bds=bands. 
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H37Rv     2 2 4 2 3 5 5 5 2 224235552 
Turkey Tur-1 1 4 3 4 4 3 3 6 7 3 434433673 
Turkey Tur-2 2 4 3 4 4 3 3 5 7 2 434433572 
Turkey Tur-3 3 4 3 4 4 3 3 6 8 3 434433683 
Turkey Tur-4 4 4 3 4 4 3 3 6 8 3 434433683 
Turkey Tur-5 5 4 3 2 4 3 3 5 6 2 432433562 
Turkey Tur-6 6 4 3 4 4 3 3 6 8 3 434433683 
Turkey Tur-7 7 4 3 4 4 2 3 6 7 3 434423673 
Turkey Tur-8 8 4 3 4 4 3 3 6 7 3 434433673 
Turkey Tur-9 9 4 3 4 4 3 3 5 7 2 434433572 
Turkey Tur-10 10 4 3 4 4 3 3 5 7 2 434433572 
Turkey Tur-11 11 4 3 4 4 3 3 5 7 2 434433572 
Turkey Tur-12 12 4 4 4 4 3 3 4 7 1 444433471 
Turkey Tur-13 13 4 3 4 4 3 4 6 7 3 434434673 
Turkey Tur-14 14 4 3bds 4 4 3 3 6 7 3 4X4433673 
Turkey Tur-15 15 4 3 4 4 3 3 6 7 3 434433673 
Turkey Tur-16 16 4 3 4 4 3 3 5 ND 2 4344335N2 
Turkey Tur-17 17 4 3 4 4 3 3 6 7 3 434433673 
Turkey Tur-18 18 5 3 4 4 3 3 6 7 3 534433673 
Bulg Tur-19 20_10 4 3 4 2 3 3 1 11 3 4342331a3 
Bulg Tur-20 24_10 4 3 4 4 3 3 1 11 3 4344331a3 
Bulg Tur-21 78 4 2 4 4 3 3 1 11 3 4244331a3 
Japan T3O-1 R1-1 1 3 4 4 3 3 6 8 3 134433683 
Japan T3O-2 R1-2 2 2bds 4 4 3 3 5 6 2 2X4433562 
Japan T3O-3 R1-3 2 3 4 4 3 3 6 6 3 234433663 
Japan T3O-4 R1-4 ND ND ND ND ND ND ND ND ND ND 
Japan T3O-5 R1-5 2 4 4 4 3 2 6 4 3 244432643 
Japan T3O-6 R1-6 2 3 4 4 3 5 6 8 3 234435683 
Japan T3O-7 R1-7 2 3 4 4 3 3 6 8 3 234433683 
Japan T3O-8 R1-8 2 3 4 4 3 3 6 8 3 234433683 
Japan T3O-9 R1-9 2 3 4 4 3 3 2 9 4 234433294 
Japan T3O-10 R1-11 2 3 4 4 3 3 7 8 4 234433784 
Japan T3O-11 R1-12 2 3 5 4 3 3 6 6 3 235433663 
Japan T3O-12 R1-13 2 3 4 4 3 3 6 5 3 234433653 
Japan T3O-13 R1-14 2 3 4 4 3 4 6 8 3 234434683 
Japan T3O-14 R1-15 2 3 4 4 3 3 6 5 3 234433653 
Japan T3O-15 R4-1 2 3 4 4 3 3 6 8 3 234433683 
Japan T3O-16 R6-1 2 3 4 4 3 3 6 3 3 234433633 
Japan T3O-17 R6-2 3 3 3 4 3 3 6 8 3 333433683 
Japan T3O-18 R6-3 2 3 4 4 3 3 6 8 3 234433683 
Japan T3O-19 R6-4 2 3 4 4 3 5 6 ND 3 2344356N3 
Japan T3O-20 R6-5 2 3 4 4 3 ND 6 ND ND 23443N6NN 
Japan T3O-21 R6-7 2 3 4 4 3 5 6 8 3 234435683 
Japan T3O-22 R6-8 2 3 4 4 3 3 6 8 3 234433683 
Japan T3O-23 R6-9 2 3 4 4 3 3 7 9 4 234433794 
Japan T3O-24 R6-10 3 3 4 4 3 2 6 8 3 334432683 
Japan T3O-25 R6-11 3 3 4 4 3 3 6 6 3 334433663 
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Table 2: 
SNPs 
characteristic 
of T3-Osa-
Tur lineage. 
          
ref=reference; alt=alternative; aa=amino acid; CDS= coding Sequence; NS= non-
synonymous; S=synonymous. Positions are given according to H37Rv genome numbering. 
 
position ref alt ref_codon alt_codon ref_aa alt_aa locus_tag gene coding? type 
401678 C A CCC CAC P H Rv0336 
Hypothetical 
protein 
CDS NS 
1562830 G C TTG TTC L F Rv1387 PPE20 CDS NS 
2208627 C G CGG GGG R G Rv1965 yrbE3B CDS NS 
2563611 G A GGG GGA G G Rv2291 sseB CDS S 
3985860 C T CTG TTG L L Rv3546 fadA5 CDS S 
4182566 G T TGG TTG W L Rv3731 ligC CDS NS 
4239334 T C GTG GCG V A Rv3792 aftA CDS NS 
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Table 3: Human and TB genetics, history and palaeontology supporting different evolutionary rate scenarios. Mitoch : data derived from human 
mitochondrial DNA. WGS: data derived from Whole Genome Sequencing. Data supporting the corresponding timing are written in bold. Data contradicting timing are underlined. Supported 
timing is written in bold. 
 SLOW evolution rate scenario INTERMEDIATE evolution rate scenario 
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ago (Rotschild, 
2001) 
Various genetic and paleoanthro-
pological data indicate an Out-of-
Africa demographic expansion ca. 
60,000 y ago. WGS: Caucasus 
Hunter Gatherers (CHG) isolated 
from ancestors of farmers around 
25,000 y ago (Jones, 2015) 
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 Mitoch: various lineages 
present in Altai during Iron 
Age 2,500 y ago (Gonzalez-
Ruiz, 2012)  
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TB in human 
remains of 4,500y 
ago in Baïkal region 
(Lieverse, 2014) 
CHG contributed to the gene pool of 
East Europe (including Turkey) at 
least stretching to Kyrgystan (Jones, 
2015) 
Relatedness between 
Tungusic languages 
(Japanese, Ryuku and 
Ainu) and Turkic 
languages ; time of 
divergence: at leats 6,000 
y ago  (Yunusbaiev, 2015) 
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4,500y-old 
remains with 
TB in Baïkal 
region 
(Lieverse, 
2014) 
Specific chromosomal tracts 
in mongolic populations likely 
herited from Mongolic empire   
(Yunusbaiev, 2015) 
Türk empire 5th-7th century AD 
(1,600-1,400 y ago); early Islam 
empires 7th-12
th
 (1,400-900 y ago); 
Mongol empire emerging around 
1250 AD (750 y ago) (Sinor, 1990) 
C- Japan 
coloni-
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potential 
epidemic 
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Absence of 
tuberculous 
skeletons from 
Jomon period in 
Japan despite 
extensive search 
(Suzuki, 2007) 
Y-chromosom haplogroups D and C 
mostly present in Tibet and Mongolia 
colonized Japan around 20,000 and 
7,000 y ago (Hammer, 2006; Tajima, 
2004; Wang, 2014)  
Jomon culture = Hunter 
Gatherers thrived in Japan 
and built Jomon culture 
more than 12,000 y ago 
(Hammer, 2006) 
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first known 
cases of 
tuberculosis 
in Japan 
(between 
2,300 and 
1,700 y ago; 
Suzuki 2007) 
Chromosome painting: 
Uncertain admixture in 
Japanese population 
during Mongol empire 
(Hellenthal, 2014) 
5
th
-16
th
 centuries AD (1,600 to 500 
y ago) Turkic then Mongol 
military movements towards East 
(Sinor, 1990); tentative invasion 
of Japan by Genghis Khan (1274 
AD, 720 y ago) (Cheow, 2008); 
wars during Sengoku period 
(15
th
-16
th
 cent.), peace and 
prosperity during Edo-Tokugawa 
period (1603-1868 AD i.e. 400-100  
y ago) 
D- Turkey 
coloni-
zation 
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 Several migration events from 
Central Asia towards Turkey, among 
which Yamanyan step herders 5kya 
(Jones, 2015) and Scythian 2.5kya  
(Gonzalez-Ruiz, 2012); Y-
chromosome C haplogroups in 
Turkey and Chechenia (Nasidze, 
2004) 
Proto-Turkic language 
seems to have been used 
from 4,000 to 2,000 y ago 
and influence seems to 
have given rise to many 
languages among which 
Turkish (Yunusbaiev, 
2015; Dybo, 2008) 
T
u
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 WGS: admixture of 
Mongolian chromosomal 
tracts in Turkish population 
dated back to 9
th
 to 17
th
 
century i.e. 1,200 to 400 y 
ago (Yunusbaiev, 2015); 
chromosome painting: 
gene influx from NE Asia to 
Uzbekistan and further 
West around 700 y ago 
(Hellenthal, 2014) 
5th-16th centuries (1,600 to 500 y 
ago) Turkic then Mongol military 
movements towards East and 
West with transient conquests 
(Sinor, 1990) 
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Figure 1 
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Figure 2 
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Figure 3 
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Lineage 4 
emergence
40,000-30,000 ya
Ural-Super-
lineage 
emergence
~5,000-2,000 ya
T3 Ethiopia 
emergence
4,000-
1,500 ya
Lineage 1 
emergence and 
dispersal
60,000-40,000 ya
T3-Osaka 
epidemics
~400 ya
T3-Osa-Tur 
emergence
~2,000-1,000 ya
T3-Osa-Tur 
divergence / 
emergence of Tur 
and T3-Osaka
~2,000-800 ya
MRCA MTBC
-70,000 ya 
Tur 
emergence
~2,000-800 
ya
Tur divergence
towards 
Bulgaria      
~200 ya
 
Figure 4 
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Figure 5- Mutation rate as a function of pairwise divergence 
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Highlights 
 Whole Genome data prove that T3-Osaka and Tur lineages are highly related  
 T3-Osa-Tur Most Recent Common Ancestor (MRCA) may date back to Mongol Empire 
 This MRCA may serve as first calibration point for Euro-American TB molecular clock 
